Absence of Clinical GVHD and the In Vivo Induction of Regulatory T cells following Facilitating Cell Transplantation
暂无分享,去创建一个
[1] D. Klatzmann,et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. , 2003, The Journal of clinical investigation.
[2] F. Ramsdell,et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.
[3] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[4] T. Nomura,et al. Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .
[5] S. Wahl,et al. TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression. , 2003, Cytokine & growth factor reviews.
[6] C. Fathman,et al. Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation , 2002, The Journal of experimental medicine.
[7] A. Santoni,et al. Bone marrow CD8 T cells are in a different activation state than those in lymphoid periphery , 2002, European journal of immunology.
[8] B. Blazar,et al. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. , 2002, Blood.
[9] W. Strober,et al. Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β , 2001, The Journal of experimental medicine.
[10] D. Matesic,et al. CD4+CD25+ regulatory cells in acquired MHC tolerance , 2001, Immunological reviews.
[11] Y. Colson,et al. Characterization of a newly discovered T-cell receptor β-chain heterodimer expressed on a CD8+ bone marrow subpopulation that promotes allogeneic stem cell engraftment , 2000, Nature Medicine.
[12] Fiona Powrie,et al. Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.
[13] Maki Ito,et al. Graft-vs.-lymphoma effect in an allogeneic hematopoietic stem cell transplantation model. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[14] I. Weissman,et al. CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. , 1999, Immunity.
[15] M. V. D. van den Brink,et al. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. , 1999, The Journal of clinical investigation.
[16] F. Finkelman,et al. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. , 1998, Journal of immunology.
[17] J. Crawford,et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. , 1996, Blood.
[18] M. Andreeff,et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. , 1995, Blood.
[19] Simon C Watkins,et al. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. , 1994, Blood.
[20] P. Martin,et al. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans , 1993, The Journal of experimental medicine.
[21] J. Ferrara,et al. Cytokine dysregulation and acute graft-versus-host disease. , 1992, Blood.
[22] A. Rimm,et al. Increasing Utilization of Allogeneic Bone Marrow Transplantation , 1992, Annals of Internal Medicine.
[23] A. Rimm,et al. T-cell depletion of HLA-identical transplants in leukemia. , 1991, Blood.
[24] R. Hoffmann,et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. , 1988 .
[25] J. Sprent,et al. T cell subsets and graft-versus-host disease. , 1987, Transplantation.
[26] S. Strober,et al. Cloned natural suppressor cells prevent lethal graft-vs-host disease. , 1987, Journal of immunology.
[27] J. Sprent,et al. Functions of Purified L3T4+ and Lyt‐2+ Cells in vitro and in vivo , 1986, Immunological reviews.
[28] E. Gleichmann,et al. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.- host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes , 1983, The Journal of experimental medicine.
[29] G. McDonald,et al. Gastrointestinal graft‐versus‐host disease in man: A clinicopathologic study of the rectal biopsy , 1979, The American journal of surgical pathology.